Quantum non-reliance on prior financials; restatement due to revenue & warrant accounting; estimates revenue/NI increase

QUANTUM CORP /DE/

Board concluded non-reliance on audited FY2022 & FY2023 and Q1 FY2024 financials; restatement underway.
Errors: inconsistent application of ASC 606 (standalone selling price) and misclassification of warrants as equity under ASC 815.
Company estimates restatement will increase previously reported revenue and net income for affected periods; no cash impact.
Lenders waived covenant tests related to restatement; issued 2M warrants at $0.46/share as part of amendments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.